CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Balance at Dec. 31, 2022	$ 2,451,294	$ 19,470	$ 1,755,963	$ (49,868)	$ 725,729
Balance, Shares at Dec. 31, 2022		155,759,000
Net issuance of common stock under stock-based plans	(3,870)	$ 73	(3,943)
Net issuance of common stock under stock-based plans (in shares)		579,000
Stock-based compensation expense	20,332		20,332
Repurchase of common stock	(98,048)	$ (112)			(97,936)
Repurchase of common stock (in shares)		(893,000)
Cash dividends	(17,179)				(17,179)
Settlements of convertible notes	0	$ 41	(41)
Settlements of convertible notes (in shares)		324,000
Exercise of convertible notes hedge call options	0	$ (41)	41
Exercise of convertible notes hedge call options (in shares)		(324,000)
Net income	83,531				83,531
Other comprehensive income (loss)	13,402			13,402
Balance at Apr. 02, 2023	2,449,462	$ 19,431	1,772,352	(36,466)	694,145
Balance, Shares at Apr. 02, 2023		155,445,000
Balance at Dec. 31, 2023	2,525,897	$ 19,087	1,827,274	(26,978)	706,514
Balance, Shares at Dec. 31, 2023		152,698,000
Net issuance of common stock under stock-based plans	3,816	$ 58	3,758
Net issuance of common stock under stock-based plans (in shares)		466,000
Stock-based compensation expense	17,158		17,158
Warrant exercises		$ 102	(102)
Warrant exercises (in shares)		813
Repurchase of common stock	(22,095)	$ (27)			(22,068)
Repurchase of common stock (in shares)		(220,000)
Cash dividends	(18,383)				(18,383)
Net income	64,197				64,197
Other comprehensive income (loss)	(12,761)			(12,761)
Balance at Mar. 31, 2024	$ 2,557,829	$ 19,220	$ 1,848,088	$ (39,739)	$ 730,260
Balance, Shares at Mar. 31, 2024		153,757,000